Abstract
Aims
To describe optical coherence tomography (OCT) findings in patients with in-stent restenosis (ISR) and determine predictors of neointimal patterns and neoatherosclerosis.
Methods and results
Patients undergoing OCT prior to PCI for ISR in three European centres were included. Analyses were performed in a core laboratory. Qualitative and quantitative [gray-scale signal intensity (GSI)] neointima analyses were performed on a per quadrant basis. A total of 107 patients were included. Predominantly homogeneous lesions included 4.5% (0.0–14.3) non-homogeneous quadrants, while predominantly non-homogeneous ones included 28.1% (20.3–37.5) homogeneous quadrants. Mean GSI values differed significantly between homogeneous [108.4 (92.5–123.6)], non-homogeneous [79.9 (61.2–95.9)], and neoatherosclerosis [88.3 (72.8–104.9)] quadrants (p < 0.001 for all comparisons). Stent underexpansion was observed in 48.5% and 61.1% of lesions, respectively (p = 0.225). Female sex and maximal neointimal thickness independently correlate with a non-homogeneous pattern, while angiographic pattern and diabetes mellitus inversely correlate with such pattern. Time from index stenting procedure was the only independent predictor of neoatherosclerosis.
Conclusions
Different neointimal patterns coexist in a significant proportion of ISR lesions. GSI values differ significantly between neointimal categories. Neoatherosclerosis is a time-dependent phenomenon, displaying different time courses in DES compared to BMS, with earlier appearance in the former group. Stent underexpansion is a frequent finding in patients with ISR.
Similar content being viewed by others
References
Cassese S, Byrne RA, Tada T, Pinieck S, Joner M, Ibrahim T, King LA, Fusaro M, Laugwitz KL, Kastrati A (2014) Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography. Heart 100(2):153–159. https://doi.org/10.1136/heartjnl-2013-304933
Werner N, Nickenig G, Sinning JM (2018) Complex PCI procedures: challenges for the interventional cardiologist. Clin Res Cardiol 107(Suppl 2):64–73. https://doi.org/10.1007/s00392-018-1316-1
Gonzalo N, Serruys PW, Okamura T, van Beusekom HM, Garcia-Garcia HM, van Soest G, van der Giessen W, Regar E (2009) Optical coherence tomography patterns of stent restenosis. Am Heart J 158(2):284–293. https://doi.org/10.1016/j.ahj.2009.06.004
Kufner S, Xhepa E, Lutter C, Cassese S, Joner M (2017) Optical coherence tomography in drugeluting stent restenosis: a technique in need of a strategy. Minerva Cardioangiol 65(1):61–67. https://doi.org/10.23736/S0026-4725.16.04241-9
Lutter C, Mori H, Yahagi K, Ladich E, Joner M, Kutys R, Fowler D, Romero M, Narula J, Virmani R, Finn AV (2016) Histopathological differential diagnosis of optical coherence tomographic image interpretation after stenting. JACC Cardiovasc Interv 9(24):2511–2523. https://doi.org/10.1016/j.jcin.2016.09.016
Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R (2006) Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48(1):193–202. https://doi.org/10.1016/j.jacc.2006.03.042
Nakano M, Otsuka F, Yahagi K, Sakakura K, Kutys R, Ladich ER, Finn AV, Kolodgie FD, Virmani R (2013) Human autopsy study of drug-eluting stents restenosis: histomorphological predictors and neointimal characteristics. Eur Heart J 34(42):3304–3313. https://doi.org/10.1093/eurheartj/eht241
Habara M, Terashima M, Nasu K, Kaneda H, Inoue K, Ito T, Kamikawa S, Kurita T, Tanaka N, Kimura M, Kinoshita Y, Tsuchikane E, Matsuo H, Ueno K, Katoh O, Suzuki T (2011) Difference of tissue characteristics between early and very late restenosis lesions after bare-metal stent implantation: an optical coherence tomography study. Circ Cardiovasc Interv 4(3):232–238. https://doi.org/10.1161/CIRCINTERVENTIONS.110.959999
Goto K, Takebayashi H, Kihara Y, Hagikura A, Fujiwara Y, Kikuta Y, Sato K, Kodama S, Taniguchi M, Hiramatsu S, Haruta S (2013) Appearance of neointima according to stent type and restenotic phase: analysis by optical coherence tomography. EuroIntervention 9(5):601–607. https://doi.org/10.4244/EIJV9I5A96
Song L, Mintz GS, Yin D, Yamamoto MH, Chin CY, Matsumura M, Kirtane AJ, Parikh MA, Moses JW, Ali ZA, Shlofmitz RA, Maehara A (2017) Characteristics of early versus late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study. EuroIntervention. https://doi.org/10.4244/EIJ-D-16-00787
Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, Pichard AD, Kent KM, Stone GW, Leon MB (1999) Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 100(18):1872–1878
Otsuka F, Byrne RA, Yahagi K, Mori H, Ladich E, Fowler DR, Kutys R, Xhepa E, Kastrati A, Virmani R, Joner M (2015) Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment. Eur Heart J 36(32):2147–2159. https://doi.org/10.1093/eurheartj/ehv205
Malle C, Tada T, Steigerwald K, Ughi GJ, Schuster T, Nakano M, Massberg S, Jehle J, Guagliumi G, Kastrati A, Virmani R, Byrne RA, Joner M (2013) Tissue characterization after drug-eluting stent implantation using optical coherence tomography. Arterioscler Thromb Vasc Biol 33(6):1376–1383. https://doi.org/10.1161/ATVBAHA.113.301227
Koppara T, Tada T, Xhepa E, Kufner S, Byrne RA, Ibrahim T, Laugwitz KL, Kastrati A, Joner M (2018) Randomised comparison of vascular response to biodegradable polymer sirolimus eluting and permanent polymer everolimus eluting stents: an optical coherence tomography study. Int J Cardiol 258:42–49. https://doi.org/10.1016/j.ijcard.2018.01.011
Tibshirani R (1997) The lasso method for variable selection in the Cox model. Stat Med 16(4):385–395
Alfonso F, Byrne RA, Rivero F, Kastrati A (2014) Current treatment of in-stent restenosis. J Am Coll Cardiol 63(24):2659–2673. https://doi.org/10.1016/j.jacc.2014.02.545
Colleran R, Kastrati A (2018) Percutaneous coronary intervention: balloons, stents and scaffolds. Clin Res Cardiol 107(Suppl 2):55–63. https://doi.org/10.1007/s00392-018-1328-x
Tada T, Kadota K, Hosogi S, Miyake K, Ohya M, Amano H, Izawa Y, Kanazawa T, Kubo S, Ichinohe T, Hyoudou Y, Hayakawa Y, Sabbah MM, Otsuru S, Hasegawa D, Habara S, Tanaka H, Fuku Y, Katoh H, Goto T, Mitsudo K (2015) Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation. Eur Heart J Cardiovasc Imaging 16(10):1101–1111. https://doi.org/10.1093/ehjci/jev031
Sakakura K, Joner M, Virmani R (2014) Does neointimal characterization following DES implantation predict long-term outcomes? JACC Cardiovasc Imaging 7(8):796–798. https://doi.org/10.1016/j.jcmg.2014.06.002
Rheude TA, Xhepa E, Byrne RA (2017) Markedly different tissue types on optical coherence tomography imaging in a patient with multiple lesion drug-eluting stent in-stent restenosis. Catheter Cardiovasc Interv 89(6):E181–E184. https://doi.org/10.1002/ccd.26694
Adriaenssens T, Joner M, Godschalk TC, Malik N, Alfonso F, Xhepa E, De Cock D, Komukai K, Tada T, Cuesta J, Sirbu V, Feldman LJ, Neumann FJ, Goodall AH, Heestermans T, Buysschaert I, Hlinomaz O, Belmans A, Desmet W, Ten Berg JM, Gershlick AH, Massberg S, Kastrati A, Guagliumi G, Byrne RA (2017) Prevention of late stent thrombosis by an interdisciplinary global european effort. Optical coherence tomography findings in patients with coronary stent thrombosis: a report of the PRESTIGE consortium (prevention of late stent thrombosis by an interdisciplinary global european effort). Circulation 136(11):1007–1021. https://doi.org/10.1161/CIRCULATIONAHA.117.026788
Alfonso F, Fernandez-Vina F, Medina M, Hernandez R (2013) Neoatherosclerosis: the missing link between very late stent thrombosis and very late in-stent restenosis. J Am Coll Cardiol 61(12):e155. https://doi.org/10.1016/j.jacc.2012.09.071
Otsuka F, Vorpahl M, Nakano M, Foerst J, Newell JB, Sakakura K, Kutys R, Ladich E, Finn AV, Kolodgie FD, Virmani R (2014) Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans. Circulation 129(2):211–223. https://doi.org/10.1161/CIRCULATIONAHA.113.001790
Nakazawa G, Otsuka F, Nakano M, Vorpahl M, Yazdani SK, Ladich E, Kolodgie FD, Finn AV, Virmani R (2011) The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol 57(11):1314–1322. https://doi.org/10.1016/j.jacc.2011.01.011
Miura K, Tada T, Habara S, Kuwayama A, Shimada T, Ohya M, Murai R, Amano H, Kubo S, Otsuru S, Tanaka H, Fuku Y, Goto T, Kadota K (2018) Optical coherence tomography predictors for recurrent restenosis after paclitaxel-coated balloon angioplasty for drug-eluting stent restenosis. Circ J. https://doi.org/10.1253/circj.CJ-18-0464
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to declare.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Xhepa, E., Byrne, R.A., Rivero, F. et al. Qualitative and quantitative neointimal characterization by optical coherence tomography in patients presenting with in-stent restenosis. Clin Res Cardiol 108, 1059–1068 (2019). https://doi.org/10.1007/s00392-019-01439-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-019-01439-5